Epimeron Inc. (“Epimeron”), a Calgary-based biotechnology company, today announced that it has licensed certain of its proprietary technologies to a US-based company. The terms of the agreement were not disclosed.
The PED virus kills young piglets at an astonishing rate with a near 100% mortality rate in suckling pigs. A Canadian effort has been launched to understand and stop the disease to protect the young pigs and to aid the pig industry in North America.
Genome Canada is pleased to advise the research community of an upcoming funding opportunity – the 2015 Large-Scale Applied Research Project Competition Natural Resources and the Environment: Sector Challenges – Genomic Solutions. This Competition is anticipated to be formally launched in Spring 2015 with detailed guidelines and application forms available at that time.
Marc LePage, President and CEO of Génome Québec, was in London today for the announcement of a partnership between Université Laval and Oxford University. The event took place in the company of Premier Philippe Couillard, who was speaking at a conference of the Canada–United Kingdom Chamber of Commerce.
Genome Canada is pleased to announce a partnership with the ERA-NET consortium “E-Rare-3” and participation in the 2015 "European Research Projects on Rare Diseases" Joint Transnational Call.
Genome Canada wishes to commend the Government of Canada on a comprehensive new strategy – Seizing Canada’s Moment: Moving Forward in Science Technology and Innovation 2014.
In particular, we are pleased to see prominent recognition of the role that new technologies, including genomics, can play in transforming our economy and enhancing Canadians’ quality of life.